ResearcherOregon Health & Science UniversityActive in the last 2 years
Ethan S. Agritelley
Matched on ORCID iD 0009-0009-2728-0552; OpenAlex author ID A5094224328. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 39
2025: 3 papers · 2026: 3 papers
Papers 6
- Comparing traditional versus total neoadjuvant chemotherapy for patients with localized pancreatic cancer. Co-author DOI 10.1016/j.hpb.2025.11.001↗
- Preparing for the Inevitable: Early Comprehensive Genomic Profiling for Patients With Localized Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1200/op-25-00548↗
- Epigenetic progression of pancreatic cancer to aggressive subtypes involves alternate routes of lineage reprogramming in subtype-intermediate progenitor cells Co-author DOI 10.64898/2026.09.28.754674↗
- A platform for multisite immune profiling of premetastatic pancreatic cancer at single-cell resolution. Co-author DOI 10.1007/s00262-025-04146-5↗
- SMAD4 Alterations are a Predictive Biomarker to Guide First-line Chemotherapy Selection for the Neoadjuvant Treatment of Localized Pancreatic Cancer : A Multic… Co-author DOI 10.1097/sla.0000000000006966↗
- A window trial in metastatic pancreatic ductal adenocarcinoma reveals resistance mechanisms to targeting the KRAS-MEK pathway Co-author DOI 10.64898/2025.12.12.693851↗
Closest collaborators
The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Daniel P. Nussbaum · 4 shared papers, 2025–2026 · strength 1.06
- Paper Comparing traditional versus total neoadjuvant chemotherapy for patients with localized pancreatic cancer. DOI 10.1016/j.hpb.2025.11.001↗
- Paper Preparing for the Inevitable: Early Comprehensive Genomic Profiling for Patients With Localized Pancreatic Ductal Adeno… DOI 10.1200/op-25-00548↗
- Paper A platform for multisite immune profiling of premetastatic pancreatic cancer at single-cell resolution. DOI 10.1007/s00262-025-04146-5↗
- Julia Button · 3 shared papers, 2025–2026 · strength 0.72
- Paper Comparing traditional versus total neoadjuvant chemotherapy for patients with localized pancreatic cancer. DOI 10.1016/j.hpb.2025.11.001↗
- Paper A platform for multisite immune profiling of premetastatic pancreatic cancer at single-cell resolution. DOI 10.1007/s00262-025-04146-5↗
- Paper SMAD4 Alterations are a Predictive Biomarker to Guide First-line Chemotherapy Selection for the Neoadjuvant Treatment o… DOI 10.1097/sla.0000000000006966↗
- Elishama N. Kanu · 3 shared papers, 2025–2026 · strength 0.72
- Paper Comparing traditional versus total neoadjuvant chemotherapy for patients with localized pancreatic cancer. DOI 10.1016/j.hpb.2025.11.001↗
- Paper A platform for multisite immune profiling of premetastatic pancreatic cancer at single-cell resolution. DOI 10.1007/s00262-025-04146-5↗
- Paper SMAD4 Alterations are a Predictive Biomarker to Guide First-line Chemotherapy Selection for the Neoadjuvant Treatment o… DOI 10.1097/sla.0000000000006966↗
- Ryne C. Ramaker · 2 shared papers, 2026 · strength 0.67
- Peter J. Allen · 2 shared papers, 2025–2026 · strength 0.53
- Patrick Joseph Worth · 2 shared papers, 2025–2026 · strength 0.40
- Paper Epigenetic progression of pancreatic cancer to aggressive subtypes involves alternate routes of lineage reprogramming i… DOI 10.64898/2026.09.28.754674↗
- Paper A window trial in metastatic pancreatic ductal adenocarcinoma reveals resistance mechanisms to targeting the KRAS-MEK p… DOI 10.64898/2025.12.12.693851↗
- Jason M. Link · 2 shared papers, 2025–2026 · strength 0.40
- Paper Epigenetic progression of pancreatic cancer to aggressive subtypes involves alternate routes of lineage reprogramming i… DOI 10.64898/2026.09.28.754674↗
- Paper A window trial in metastatic pancreatic ductal adenocarcinoma reveals resistance mechanisms to targeting the KRAS-MEK p… DOI 10.64898/2025.12.12.693851↗
- Motoyuki Tsuda · 2 shared papers, 2025–2026 · strength 0.40
- Paper Epigenetic progression of pancreatic cancer to aggressive subtypes involves alternate routes of lineage reprogramming i… DOI 10.64898/2026.09.28.754674↗
- Paper A window trial in metastatic pancreatic ductal adenocarcinoma reveals resistance mechanisms to targeting the KRAS-MEK p… DOI 10.64898/2025.12.12.693851↗
- Rosalie C. Sears · 2 shared papers, 2025–2026 · strength 0.40
- Paper Epigenetic progression of pancreatic cancer to aggressive subtypes involves alternate routes of lineage reprogramming i… DOI 10.64898/2026.09.28.754674↗
- Paper A window trial in metastatic pancreatic ductal adenocarcinoma reveals resistance mechanisms to targeting the KRAS-MEK p… DOI 10.64898/2025.12.12.693851↗
- Michael E. Lidsky · 2 shared papers, 2025 · strength 0.39
- Paper A platform for multisite immune profiling of premetastatic pancreatic cancer at single-cell resolution. DOI 10.1007/s00262-025-04146-5↗
- Paper SMAD4 Alterations are a Predictive Biomarker to Guide First-line Chemotherapy Selection for the Neoadjuvant Treatment o… DOI 10.1097/sla.0000000000006966↗
- John H. Strickler · 1 shared paper, 2026 · strength 0.33
- Peter J. Allen · 1 shared paper, 2026 · strength 0.33
- Brett C. Sheppard · 1 shared paper, 2026 · strength 0.25
- Kevin Hawthorne · 1 shared paper, 2026 · strength 0.25
- Ellen M. Langer · 1 shared paper, 2026 · strength 0.25
- Tao Wang · 1 shared paper, 2025 · strength 0.20
- Erika J. Crosby · 1 shared paper, 2025 · strength 0.20
- Austin M. Eckhoff · 1 shared paper, 2025 · strength 0.20
- Dan German Blazer · 1 shared paper, 2025 · strength 0.20
- Nicholas D. Klemen · 1 shared paper, 2025 · strength 0.20
- Sabino Zani · 1 shared paper, 2025 · strength 0.20
- Erin M. Dickey · 1 shared paper, 2025 · strength 0.19
- David G. Brauer · 1 shared paper, 2025 · strength 0.19
- Caitlin A. Hester · 1 shared paper, 2025 · strength 0.19
- Brian E. Diskin · 1 shared paper, 2025 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.